Focus Partners Wealth
NVO

Focus Partners Wealth’s Novo Nordisk NVO Stock Holding History

Focus Partners Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$680 – 1999
2024
Q4 		$680 Buy
+100
New +$10.8K ﹤0.01% 1890

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Focus Partners Wealth's NVO Position: Q2 2026 in Review

Focus Partners Wealth reduced its Novo Nordisk (NVO) stake by 38% in Q2 2026, selling an estimated $5.57M and leaving 211,043 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #713.

Focus Partners Wealth first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $120M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Focus Partners Wealth held 211,043 shares of Novo Nordisk worth $10.1M as of Q2 2026.
  • Focus Partners Wealth sold 129,666 Novo Nordisk shares in Q2 2026, an estimated $5.57M.
  • Novo Nordisk made up 0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #713 holding.
  • Focus Partners Wealth first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Novo Nordisk position peaked at $120M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.